Exertional syncope with a low-gradient murmur
An 82-year-old man is referred with two episodes of exertional syncope over the past month. He has a three-year history of breathlessness on climbing one flight of stairs (NYHA III). Examination reveals a slow-rising carotid pulse, a harsh ejection systolic murmur radiating to both carotids, and a soft second heart sound. Blood pressure is 105/70 mmHg. ECG shows sinus rhythm with left ventricular hypertrophy and strain. Transthoracic echocardiography reports a valve area of 0.8 cm², mean gradient 28 mmHg, peak velocity 3.5 m/s, left ventricular ejection fraction 32%, and stroke volume index 28 mL/m². Dobutamine stress echocardiography at 20 mcg/kg/min raises peak velocity to 4.2 m/s and increases stroke volume by 18%.
1. How do you interpret these echocardiographic findings, and what is the physiological rationale for the dobutamine study?
Read the worked answer
Interpretation: low-flow, low-gradient severe aortic stenosis with reduced ejection fraction.
- AVA 0.8 cm² and peak velocity 3.5 m/s would ordinarily indicate severe disease, but the mean gradient (28 mmHg) is lower than expected for a valve area of 0.8 cm².
- The reason is that gradient is flow-dependent (Gorlin/Gorlin-derived relationships): with SVI 28 mL/m² and LVEF 32%, the ventricle cannot generate normal transvalvular flow, so the gradient underestimates severity.
- This category must be split into true severe AS (valve is the primary problem) and pseudo-severe AS (the valve is only moderately narrowed but cannot open because the myopathic ventricle generates too little flow).
Role of dobutamine stress echocardiography:
- It recruits contractile reserve - defined as a ≥20% rise in stroke volume. Here the rise was only 18%, i.e. contractile reserve is borderline/limited.
- It provides a flow-adjusted estimate of valve area. If AVA remains <1.0 cm² at the higher flow, true severe AS is likely; if it rises above 1.0 cm², the valve is pseudo-severe.
The judgement the case tests is that a low gradient in a failing ventricle does not exclude severe stenosis - it mandates a flow-based assessment before concluding the patient is inoperable or that the valve is not the problem.
2. What is the next step in management, and how would the dobutamine result change your decision?
Read the worked answer
Next step: heart team assessment, not immediate surgery or immediate palliation.
- Confirm the anatomy and coronary disease (coronary angiography, CT calcium scoring if echo remains ambiguous).
- Calculate operative risk (STS score, frailty, comorbidity) because this determines the mode of intervention, not whether to intervene.
Decision logic:
- True severe AS with contractile reserve → aortic valve replacement improves survival and symptoms; TAVI is generally preferred at 82 with reduced EF and comorbidity.
- True severe AS without contractile reserve → outcomes are worse but not futile; individualised TAVI or conservative care, with a clear discussion of goals.
- Pseudo-severe AS (AVA rises to >1.0 cm² under dobutamine) → the valve is not the primary lesion; treat the heart failure with medical therapy and reconsider only if symptoms progress.
Syncope in this setting is a Class I indication for intervention if the valve is confirmed severe. The trap is to label the patient as having only moderate AS because the gradient is 28 mmHg, or to label him as inoperable because the LVEF is 32% - both are wrong until flow-adjusted assessment is complete.
3. Which single finding at dobutamine echocardiography would most strongly argue against aortic valve replacement for stenosis?
Read the worked answer
A valve area that increases to greater than 1.0 cm² once flow is augmented - i.e. pseudo-severe AS.
Reasoning:
- In pseudo-severe AS, the valve orifice is capable of opening further when the ventricle can push more flow through it. The stenosis is functionally moderate, and the dominant problem is contractile failure (often ischaemic or non-ischaemic cardiomyopathy).
- Replacing the valve would expose the patient to operative risk without correcting the main pathology, and symptoms would persist.
- By contrast, absence of contractile reserve alone is a poor prognostic marker but does not by itself exclude benefit from valve replacement.
Secondary findings that would shift the balance away from intervention include a very high predicted operative risk with severe frailty, or a clearly non-cardiac cause for the syncope - but the valve-area response is the specific discriminator the question targets.